Skip to
  1. Homepage
  2. Rare diseases
  3. Search
Simple search

Simple search

*
(*) mandatory field





 

Other search option(s)

Hyperphenylalaninemia

ORPHA238583
Synonym(s) Hyperphenylalaninemia due to BH4 deficiency
Hyperphenylalaninemia due to tetrahydrobiopterin deficiency
Non-phenylketonuric hyperphenylalaninemia
Prevalence 1-9 / 1 000 000
Inheritance Autosomal recessive
Age of onset Neonatal
Infancy
ICD-10
  • E70.1
OMIM
UMLS
  • C0751436
MeSH -
MedDRA -

Summary

Hyperphenylalaninemia (HPA) due to tetrahydrobiopterin (BH4) deficiency, also known as malignant HPA is an amino acid disorder with neonatal onset that is clinically characterized by the classic manifestations of phenylketonuria (PKA; see this term) and that later on is clinically differentiated by neurologic symptoms such as microcephaly, intellectual disability, central hypotonia, delayed motor development, peripheral spasticity and seizures, that develop and persist despite an established metabolic control of plasma phenylalanine.


(*) Required fields.

Attention: Only comments seeking to improve the quality and accuracy of information on the Orphanet website are accepted. For all other comments, please send your remarks via contact us. Only comments written in English can be processed.


Captcha image
The documents contained in this web site are presented for information purposes only. The material is in no way intended to replace professional medical care by a qualified specialist and should not be used as a basis for diagnosis or treatment.